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Benchmarking the Industry
A briefing on the Research Study
ISPE Quality Risk Management Conference
April 11th – 12th 2011
Frankfurt, Germany
Profile of DIT
• Dublin Institute of Technology (DIT) is a comprehensive, doctoral-
awarding institution, combining the academic excellence of a
traditional university with professional, career oriented learning
• DIT is committed to excellence in research.
• Led by Professor Ellen Hazelkorn, DIT's research strategy is built on
the development of research excellence in 6 key areas:
– the Creative Arts and Media, Food & Health Sciences, Environmental
Sustainability, ICT, Business and Social Economic Development and
New Materials and Technologies.
• The QS World University Rankings lists DIT among the top 3% of
the world's universities.
Somewhere, something incredible is waiting to be known
- Dr Carl Sagan
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PhD Research Study
Purpose :
The Development of an effective Science and
Risk Based Methodology for the Validation of
Manufacturing Processes used in the
Production of Human Drug and Biological
Products, based on the recent ASTM
International E2500-07 Standard and lean
principles.
Questionnaire
• Benchmarking the current implementation of
Science and Risk Based approaches across the
lifecycle within the Pharmaceutical/ Life Science
Industry.
• The study will also examine the current
regulatory environment and seek to establish
the regulatory status of Science & Risk based
applications within the Industry.
• It is planned that the results of this study will be
published in a peer reviewed journal in 2011.
Thank you for your participation
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Instructions
• Review the Information Sheet provided
• Sign and Date the Consent Form to receive your
numbered Questionnaire
• Complete the 4 page Questionnaire provided and
return to Nuala Calnan in person at any time
during the conference.
Thank You
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